Diuretic usage in heart failure: a continuing conundrum in 2005.
Several large well-designed clinical trials have shown that the use of diuretics is beneficial in patients with hypertension. However, similarly robust data regarding their role in chronic heart failure are lacking. Historically, diuretics were developed for treatment of sodium and water retention in oedematous disorders and clinically, they remain the most potent drugs available to relieve symptoms and eliminate oedema in the congested patient with heart failure. In the non-congested patient, however, diuretics continue to be used on a purely clinical basis without sufficient characterization of benefits, adverse effects, and potential influence on mortality. There are also concerns that chronic diuretic usage can cause adverse vascular effects, unfavourable neuroendocrine activation, electrolyte imbalances, and life-threatening arrhythmias. In this article, we review the limited evidence available regarding the benefits and perils of using diuretics in heart failure.
Gupta
S
S
Department of Cardiology, Wythenshawe Hospital, Manchester, UK.
Neyses
L
L
D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002303:Cardiac Output, Low / Q000188:drug therapy* / Q000503:physiopathology; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects*; D006760:Hospitalization; D006801:Humans; D009490:Neurosecretory Systems / Q000187:drug effects; D011379:Prognosis; D011788:Quality of Life; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology; D014883:Water-Electrolyte Imbalance / Q000139:chemically induced
D004232:Diuretics